Published on:
March 24, 2026
A karyotype is a complete picture of your chromosomes — the 46 thread-like structures inside each of your cells that carry your genetic information. During a karyotype test, a laboratory technician takes a sample (usually blood), cultures the cells, stains the chromosomes, and photographs them under a microscope. The chromosomes are then arranged into 23 pairs by size and shape, producing an image called a karyogram.
Humans typically have 22 pairs of autosomes and one pair of sex chromosomes (XX for females, XY for males). A karyotype test checks whether this expected pattern holds. It can reveal extra or missing chromosomes, structural rearrangements such as translocations or inversions, and deletions or duplications of chromosomal segments. These findings often carry direct consequences for reproductive health.
If you and your partner have been struggling to conceive, or if you've experienced recurrent pregnancy losses, a karyotype analysis is one of the first genetic investigations a specialist may recommend. Chromosomal abnormalities are more common among couples facing infertility than among the general population, so identifying them early can help shape the most effective treatment plan.
Karyotype testing begins with a straightforward blood draw. The laboratory isolates white blood cells (lymphocytes) from the sample and places them in a culture medium that encourages cell division. After several days of growth, technicians add a chemical called colchicine to arrest the cells during metaphase — the stage of division when chromosomes are at their most condensed and visible.
The cells are then placed on a glass slide, stained with Giemsa or another banding dye, and examined under a high-powered microscope. Each chromosome shows a characteristic banding pattern, which helps the cytogeneticist identify individual chromosomes and spot abnormalities. Multiple cells are analysed to ensure the findings are consistent and not the result of a one-off laboratory artefact.
A normal female karyotype is written as 46,XX and a normal male karyotype as 46,XY. If an abnormality is present, the notation changes. For example, a male carrying a balanced translocation between chromosomes 4 and 7 might see a result written as 46,XY,t(4;7). A woman with Turner syndrome would have a karyotype of 45,X — one sex chromosome missing entirely. These shorthand descriptions give clinicians the information they need to explain risks and guide next steps.
Results usually take between two and four weeks because the laboratory needs time to culture cells and analyse enough metaphase spreads to draw reliable conclusions. While the wait can feel frustrating, the precision of this test makes it worthwhile.
Numerical chromosomal abnormalities occur when a person has too many or too few chromosomes. Conditions such as Klinefelter syndrome (47,XXY) affect roughly 1 in 600 males and represent one of the most frequent genetic causes of male infertility. Men with Klinefelter syndrome often produce very low sperm counts or no sperm at all, because the extra X chromosome disrupts testicular function.
Turner syndrome (45,X) affects about 1 in 2,500 females. Women with the full form of Turner syndrome typically experience premature ovarian insufficiency, meaning the ovaries stop functioning well before the expected age of menopause. Mosaic forms — where only some cells carry the abnormality — can produce milder symptoms, and some affected women may conceive, in some cases with assisted reproduction techniques.
Triple X syndrome (47,XXX) and 47,XYY syndrome are other numerical variants. These conditions may have subtler effects on fertility, but they can still contribute to reduced egg or sperm quality in some individuals.
Structural abnormalities include translocations, inversions, deletions, and duplications. A balanced translocation, where two chromosomes have swapped segments without any overall loss or gain of genetic material, is particularly relevant to fertility. Carriers of balanced translocations are often healthy themselves, with no outward signs of a problem. The difficulty arises during reproduction: when eggs or sperm form, the rearranged chromosomes may segregate unevenly, producing embryos with unbalanced chromosomal complements.
Unbalanced embryos frequently fail to implant or result in early miscarriage. This is why balanced translocations are a well-recognised cause of recurrent pregnancy loss and repeated IVF failure. Identifying a translocation through karyotype testing allows fertility specialists to recommend preimplantation genetic testing (PGT) during IVF, selecting embryos with a normal or balanced chromosome arrangement before transfer.
Robertsonian translocations — fusions between two acrocentric chromosomes (most commonly chromosomes 13, 14, 15, 21, or 22) — are another structural variant with significant reproductive implications. A carrier of a Robertsonian translocation involving chromosome 21, for example, has an increased risk of having a child with Down syndrome.
Chromosomal abnormalities account for a meaningful proportion of fertility problems that would otherwise remain unexplained. Studies suggest that around 2–5% of couples with recurrent miscarriage carry a chromosomal rearrangement in one partner, compared with roughly 0.2% in the general population. Among men with severely low sperm counts, the prevalence of karyotype abnormalities rises to between 10% and 15%.
Without karyotype testing, these couples may undergo repeated treatment cycles without understanding why conception fails or pregnancies end. A karyotype result provides an explanation and, more importantly, opens the door to targeted interventions. For couples carrying balanced translocations, IVF with preimplantation genetic testing can significantly improve the chance of a healthy pregnancy. For individuals with conditions like Klinefelter syndrome, surgical sperm extraction combined with intracytoplasmic sperm injection (ICSI) may be an option, though success rates vary depending on individual circumstances.
Karyotype testing also carries value beyond the current pregnancy attempt. If either partner carries a chromosomal abnormality, genetic counselling can help them understand the implications for future pregnancies, the risks of passing conditions to their children, and the reproductive options available. This information empowers couples to make decisions that align with their values and circumstances.
Fertility specialists typically recommend karyotype testing in several specific situations. The most common indications include:
Even when a couple has no obvious risk factors, some fertility clinics include karyotype testing as a standard part of the pre-treatment workup before IVF. The rationale is straightforward: catching a chromosomal issue before treatment starts may help avoid unnecessary emotional and financial cost from cycles unlikely to succeed without genetic selection of embryos.
If you're considering starting or expanding your family and you have concerns about chromosomal health, pre-pregnancy genetic counselling offers a structured way to assess your individual risk and decide which tests make sense for your situation.
Knowing the karyotype of both partners before an IVF cycle shapes treatment strategy in several ways. If one partner carries a balanced translocation, the clinic can plan for preimplantation genetic testing for structural rearrangements (PGT-SR). This technique analyses a few cells from each embryo at the blastocyst stage, identifying which embryos have a normal or balanced chromosomal arrangement. Transferring only those embryos reduces the miscarriage rate and increases the likelihood of a live birth.
For men with Klinefelter syndrome, karyotype results guide the urologist and reproductive endocrinologist toward micro-TESE (microscopic testicular sperm extraction), which retrieves small numbers of viable sperm directly from testicular tissue. Sperm retrieval rates with micro-TESE in men with Klinefelter syndrome vary, but the procedure offers a possibility that might otherwise be overlooked without the karyotype result.
When a pregnancy ends in miscarriage, karyotype analysis of the pregnancy tissue (products of conception) can determine whether a chromosomal abnormality in the embryo caused the loss. This information is especially useful for couples who have experienced multiple losses. If the karyotype of the miscarried pregnancy is abnormal, the prognosis for future pregnancies may be better than couples expect — particularly if their own karyotypes are normal, because sporadic chromosomal errors in embryos become more common with age and don't necessarily recur.
Conversely, if miscarried tissue returns a normal karyotype, the specialist will look more carefully at other causes such as uterine anatomy, thrombophilia, or immune factors. Each result narrows the field and brings the couple closer to an effective treatment plan.
Karyotype testing is powerful, but it has boundaries. Standard karyotyping can detect abnormalities involving large segments of chromosomes — roughly five million base pairs or more. Smaller deletions, duplications, or single-gene mutations fall below its resolution. For these, more targeted tests such as chromosomal microarray analysis or carrier genetic testing (CGT) may be needed.
A normal karyotype result does not rule out all genetic causes of infertility. Conditions like Y-chromosome microdeletions in men, or mutations in specific fertility-related genes such as FMR1 (linked to fragile X premature ovarian insufficiency), require separate testing. Your clinical geneticist or genetic counsellor can advise on which additional tests to consider based on your clinical picture and family history.
Mosaicism — where some cells have a normal chromosome complement and others do not — can also occasionally be missed if the abnormal cell line is present in a small percentage of cells. Laboratories analyse a standard number of metaphase spreads (usually 20–30), and a low-level mosaic may require extended analysis to detect.
Despite these limitations, karyotype testing remains a cornerstone of the fertility investigation. Its ability to identify major chromosomal abnormalities that directly affect conception, pregnancy maintenance, and the health of future children makes it an important part of the diagnostic process.
The test requires a standard blood draw, so the experience is similar to any routine blood test. You may feel a brief sting from the needle and mild bruising at the puncture site. There are no significant risks associated with the test itself. Results typically take two to four weeks because the laboratory needs time to culture cells and analyse chromosomes under the microscope.
No. A normal karyotype means neither partner carries a detectable chromosomal abnormality, which removes one potential barrier to conception. However, fertility depends on many factors — hormonal balance, egg and sperm quality, uterine health, and timing among them. A normal karyotype is reassuring but does not guarantee pregnancy. Your fertility specialist will assess all contributing factors as part of a comprehensive workup.
Yes. Because a balanced chromosomal rearrangement can be present in either partner without causing any symptoms, testing only one person risks missing important information. Fertility clinics typically recommend that both partners undergo karyotype testing when there is a history of recurrent miscarriage, unexplained infertility, or severe sperm abnormalities.
An abnormal karyotype does not necessarily mean you cannot have children. It means your specialist can tailor treatment to your specific situation. Options may include IVF with preimplantation genetic testing to select chromosomally balanced embryos, use of donor eggs or sperm, or other assisted reproduction strategies. A genetic counsellor will walk you through the implications and help you understand your reproductive choices.
Karyotype testing examines the number and structure of your chromosomes — the large-scale architecture of your genome. Carrier screening (also known as carrier genetic testing) looks for mutations in specific genes that could cause inherited diseases such as cystic fibrosis, sickle cell disease, or spinal muscular atrophy. The two tests are complementary: karyotyping catches structural and numerical chromosome problems, while carrier screening identifies single-gene conditions that would be invisible on a karyotype.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised diagnosis and treatment. If you have concerns about your fertility or chromosomal health, please speak to your GP or a specialist for guidance tailored to your individual circumstances.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
